Skip to main content

Eli Lilly’s stock rises as results beat expectations, Mounjaro sales surge

Mounjaro revenues beat lofty expectations as Lilly realizes higher prices in the U.S.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.